Vukusic Sandra, Confavreux Christian
European Database for Multiple Sclerosis (EDMUS) Coordinating Center and Service de Neurologie A, Hôpital Neurologique, Hospices Civils de Lyon, 59 Boulevard Pinel, Lyons Cedex 03, 69394, France.
J Neurol Sci. 2003 Feb 15;206(2):153-5. doi: 10.1016/s0022-510x(02)00427-6.
The progressive phase of multiple sclerosis (MS) is the one most often associated with irreversible accumulation of disability. An important question remains about the place of primary progressive MS (PP-MS): does it form an integral part of the disease spectrum, or is it maybe a distinct entity? This question could apparently be very theoretical, but it is not, as patients with PP-MS remain orphans when regarding disease-modifying treatments. Thus, they are usually excluded from therapeutic trials. A clue to this question could be the comparison between the different MS subtypes with a progressive phase. We discuss here the clinical similarities and differences between secondary and primary progressive MS.
多发性硬化症(MS)的进展期是最常与不可逆的残疾累积相关的阶段。关于原发性进展型多发性硬化症(PP-MS)的地位仍存在一个重要问题:它是疾病谱的一个组成部分,还是可能是一个独特的实体?这个问题表面上可能非常理论化,但实际上并非如此,因为在考虑疾病修正治疗时,PP-MS患者仍然没有相应的治疗方法。因此,他们通常被排除在治疗试验之外。这个问题的一个线索可能是对不同进展期MS亚型之间的比较。我们在此讨论继发性和原发性进展型MS之间的临床异同。